IFNG and thyroid cancer: The TSH‐CAR‐T cells demonstrate effective antitumor activity against TSHR‐positive differentiated thyroid cancer (DTC) cell lines in vitro, accompanied by cytokine release (IFNγ, IL‐2) and robust proliferation.